These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 451947)

  • 1. [Modern substitution therapy does not just lengthen the lives of hemophiliacs].
    Koller F
    Ther Umsch; 1979 Apr; 36(4):291-3. PubMed ID: 451947
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)].
    Hartmann S
    Ther Umsch; 1979 Apr; 36(4):301-6. PubMed ID: 451948
    [No Abstract]   [Full Text] [Related]  

  • 3. Home management of hemophilia A.
    Van Eys J
    J Tenn Med Assoc; 1971 May; 64(5):407-10. PubMed ID: 5091669
    [No Abstract]   [Full Text] [Related]  

  • 4. A guide for home treatment--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():1-27. PubMed ID: 6770457
    [No Abstract]   [Full Text] [Related]  

  • 5. The economics of immune tolerance and treatment of hemophiliacs with inhibitors.
    Kessler CM; Aledort LM
    Vox Sang; 1996; 70 Suppl 1():74-6. PubMed ID: 8869476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII: maximal benefit?
    Nour-Eldin F
    Eur J Med; 1992 Apr; 1(1):55-7. PubMed ID: 1341979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Substitution therapy in operations on hemophiliacs].
    Meili EO; Kaufmann L; Schneider W
    Ther Umsch; 1979 Apr; 36(4):307-10. PubMed ID: 451949
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of plasma cryoprecipitates in hemophiliacs].
    Kleimans M; Kordich L; Zdrojewski D; Barraza O; Paoletti E
    Sangre (Barc); 1968; 13(3):299-304. PubMed ID: 5306119
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosage requirements for substitution therapy in hemophiliacs.
    Scand J Haematol Suppl; 1980; 35():29-54. PubMed ID: 6770459
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of porcine factor VIII.
    Kernoff PB
    Prog Clin Biol Res; 1990; 324():47-56. PubMed ID: 2106692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of haemophilic synovitis: prophylaxis.
    Lee CA
    Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction (part II).
    Evans BE
    N Y J Dent; 1981 Apr; 51(4):117-27. PubMed ID: 6784050
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
    Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
    Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Home therapy for haemophilia.
    Br Med J; 1975 Feb; 1(5955):417. PubMed ID: 1115959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Opportune treatment of hemorrhage in classical hemophilia. Study of the Hemophilia Cooperative Group].
    Rodríguez-Moyado H; Ambriz-Fernández R; Pizzuto-Chávez J; Farfán-Canto JM; Hernández-Lugo MI; Guillén-Mariscal C; Ramírez-Ortiz G; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1986 Dec; 43(12):742-9. PubMed ID: 3101718
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hemophiliacs with inhibitors: cost and effect on blood resources.
    Aledort LM; Cohen M; Hilgartner M; Lipton R
    Prog Clin Biol Res; 1984; 150():353-65. PubMed ID: 6431439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ambulatory treatment of hemorrhagic incidents in hemophiliacs with cryoprecipitate].
    Lisichkov T; Angelova Ts
    Vutr Boles; 1973; 12(3):96-9. PubMed ID: 4543117
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.